(Q61833757)
Statements
Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantation (English)
Franck Morschhauser
Damien Huglo
Giovanni Martinelli
Simon Rule
Anna Marina Liberati
Georg Hess
Harald Stein
Joachim Kalmus